腸溶軟膠囊市場規模、佔有率和成長分析（按產品類型、原料、分銷管道、應用和地區分類）- 產業預測（2026-2033 年）

預計到 2024 年，全球腸溶軟膠囊市場規模將達到 25 億美元，到 2025 年將達到 26 億美元，到 2033 年將達到 35.9 億美元，預測期（2026-2033 年）的複合年成長率為 4.1%。

全球腸溶軟膠囊市場正經歷強勁成長，其主要促進因素包括消費者對預防保健益處的日益重視、人口老化以及慢性病和營養缺乏症的增加。腸溶軟膠囊是一種將半固態和液體藥物包裹在明膠基包衣中的產品。製藥業的擴張以及在腸溶軟膠囊中添加Omega-3脂肪酸進一步推動了市場需求。健康意識的增強提高了人們對膳食補充劑的接受度，從而進一步擴大了市場潛力。針對素食消費者的創新產品開發，例如由澱粉和植物來源成分製成的非明膠軟膠囊，以及線上藥局的興起，也推動了市場成長。此外，無需用水即可服用的新型咀嚼片的開發預計也將進一步擴大腸溶軟膠囊市場。

全球腸溶軟膠囊市場促進因素

全球腸溶軟膠囊市場正經歷顯著成長，這主要歸功於企業加大研發投入，旨在提高此類膠囊的生物利用度。主要行業參與者正在擴大產能，以滿足日益成長的保健和營養補充劑需求。改進膠囊包衣技術對於鞏固市場地位至關重要。此外，主要企業採用先進的生產技術，旨在降低複雜性、減少成本並簡化藥物開發流程。這些策略措施不僅提高了營運效率，也有助於提升腸溶軟膠囊市場的整體生產力。

限制全球腸溶軟膠囊市場發展的因素

全球腸溶軟膠囊市場面臨與膠囊長期穩定性相關的重大限制因素。消費者經常會遇到保存期限問題，尤其是在軟膠囊長期儲存的情況下。這給致力於提升產品保存期限和化學穩定性的生產商帶來了挑戰，因為腸溶軟膠囊的固有特性使得最佳化過程變得複雜。因此，維持這些膠囊的完整性和有效性方面的困難可能會阻礙其市場推廣。總而言之，這些穩定性問題是腸溶軟膠囊市場成長的一大障礙。

全球腸溶軟膠囊市場趨勢

全球腸溶軟膠囊市場正經歷轉型，其主要驅動力是消費者對植物來源替代品的需求不斷成長。這主要是由於人們對動物性產品的倫理和健康影響的認知日益提高。因此，製造商正致力於創新，開發適合純素主義者的軟膠囊，以植物來源材料取代傳統的明膠包衣，以滿足日益成長的健康和環保意識消費者的需求。這項轉變不僅開闢了新的市場機遇，也迫使現有企業重新思考其產品配方，標誌著腸溶軟膠囊產業的重大變革。

目錄

介紹

• 分析目的
• 分析範圍
• 定義

分析方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場進行機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特五力分析

關鍵市場考量因素

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場魅力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究
• 技術進步

全球腸溶軟膠囊市場規模及按產品類型分類的複合年成長率（2026-2033 年）

• 明膠軟膠囊
• 素食軟膠囊

全球腸溶軟膠囊市場規模及依原料分類的複合年成長率（2026-2033）

• A型明膠（豬皮）
• B型明膠（動物骨骼和皮膚）
• 魚骨明膠
• 纖維素衍生物
• 澱粉材料

全球腸溶軟膠囊市場規模及按分銷管道分類的複合年成長率（2026-2033 年）

• 超級市場和大賣場
• 藥房和藥品商店
• 網路商家

全球腸溶軟膠囊市場規模及按應用領域分類的複合年成長率（2026-2033 年）

• 制酸劑和腸道調節劑
• 抗發炎藥
• 抗生素和抗菌藥物
• 咳嗽和感冒藥
• 保健品
• 維生素和營養補充劑
• 其他治療用途

全球腸溶軟膠囊市場規模及最終用戶複合年成長率（2026-2033 年）

• 製藥公司
• 營養保健品公司
• 藥用化妝品公司
• 食品工業

全球腸溶軟膠囊市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業市場定位（2025 年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市佔率（2025 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 年比營收比較（2023-2025）

主要企業簡介

• BASF股份公司（德國）
• Colorcon Inc.（美國）
• 富士膠囊株式會社（日本）
• 龍沙集團股份公司（瑞士）
• Now Health Group Inc.（美國）
• ProCaps集團（盧森堡）
• Super Spectrim（美國）
• 賽默飛世爾科技公司（美國）
• Key Developments
• 思銳醫藥股份有限公司 (中國)
• 軟凝膠技術公司（美國）
• EuroCaps有限公司（英國）
• Geltec Pvt. Ltd.（印度）
• Captek Softgel International, Inc.（美國）
• Elnova Pharma（加拿大）
• 最佳配方（美國）
• Pharmavite LLC（美國）
• 羅賓遜製藥公司（美國）

結論與建議

Global Enteric Softgel Market size was valued at USD 2.5 Billion in 2024 and is poised to grow from USD 2.6 Billion in 2025 to USD 3.59 Billion by 2033, growing at a CAGR of 4.1% during the forecast period (2026-2033).

The global market for enteric softgel capsules, which feature gelatin-based coatings enclosing semi-solid and liquid medications, is experiencing robust growth driven by heightened consumer awareness of preventive medicine benefits, an aging population, and an uptick in chronic and nutrient deficiency illnesses. The expanding pharmaceutical industry and the incorporation of omega-3 oils into these capsules further contribute to market demand. As health consciousness rises, greater acceptance of dietary and nutritional supplements enhances market potential. Innovations catering to vegan consumers, such as non-gelatin softgels made from starch and plant-based sources, alongside the proliferation of e-commerce pharmacies, bolster growth. Additionally, novel chewable formulations that eliminate the need for water are expected to further enhance the enteric softgel market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enteric Softgel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enteric Softgel Market Segments Analysis

Global Enteric Softgel Market is segmented by Product Type, Raw Material, Distribution Channel, Application, End User and region. Based on Product Type, the market is segmented into Gelatin Softgel Capsules and Vegetarian Softgel Capsules. Based on Raw Material, the market is segmented into Type-A Gelatin (Pork Skin), Type-B Gelatin (Animal Bones and Skin), Fish Bone Gelatin, Cellulose Derivatives and Starch Material. Based on Distribution Channel, the market is segmented into Supermarket and Hypermarket, Pharmacy and Drug store and Online Provider. Based on Application, the market is segmented into Antacid and Antiflatulent Preparations, Anti-inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplements, Vitamin and Dietary Supplements and Other Therapeutic Applications. Based on End User, the market is segmented into Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Food Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Enteric Softgel Market

The Global Enteric Softgel market is experiencing significant growth, primarily driven by increasing investments in research and development aimed at enhancing the bioavailability of these capsules. Key industry players are expanding production capacities to satisfy the rising demand for health and nutritional supplements. Efforts to improve capsule coating technology are essential for establishing a more robust market presence. Additionally, the implementation of advanced manufacturing techniques by leading companies focuses on minimizing complexity, lowering costs, and streamlining drug development processes. These strategic initiatives not only enhance business efficiency but also contribute to increased productivity in the enteric softgel segment of the market.

Restraints in the Global Enteric Softgel Market

The Global Enteric Softgel market faces significant constraints related to the stability of these capsules over time. Consumers often encounter issues with shelf-life, particularly when these softgels are stored beyond an extended period. This poses challenges for manufacturers seeking to enhance the shelf-life and chemical stability of their products, as the inherent characteristics of enteric softgels complicate the optimization process. As a result, the difficulties associated with maintaining the integrity and effectiveness of these capsules can hinder their widespread adoption in the market. Overall, these stability concerns represent a notable barrier to the growth of the enteric softgel segment.

Market Trends of the Global Enteric Softgel Market

The Global Enteric Softgel market is witnessing a transformative shift driven by the growing trend toward plant-based alternatives, as consumers increasingly adopt vegan lifestyles. This shift is primarily fueled by heightened awareness of the ethical and health-related implications of animal-derived products. As a result, manufacturers are innovating to develop vegan-friendly softgel capsules that replace traditional gelatin coatings with plant-based materials, catering to the rising demand from health-conscious and environmentally aware consumers. This transition not only opens new market opportunities but also compels established players to rethink their product formulations, marking a significant evolution in the enteric softgel landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Enteric Softgel Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Gelatin Softgel Capsules
• Vegetarian Softgel Capsules

Global Enteric Softgel Market Size by Raw Material & CAGR (2026-2033)

• Market Overview
• Type-A Gelatin (Pork Skin)
• Type-B Gelatin (Animal Bones and Skin)
• Fish Bone Gelatin
• Cellulose Derivatives
• Starch Material

Global Enteric Softgel Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Supermarket and Hypermarket
• Pharmacy and Drug store
• Online Provider

Global Enteric Softgel Market Size by Application & CAGR (2026-2033)

• Market Overview
• Antacid and Antiflatulent Preparations
• Anti-inflammatory Drugs
• Antibiotic and Antibacterial Drugs
• Cough and Cold Preparations
• Health Supplements
• Vitamin and Dietary Supplements
• Other Therapeutic Applications

Global Enteric Softgel Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Food Industry

Global Enteric Softgel Market Size & CAGR (2026-2033)

• North America (Product Type, Raw Material, Distribution Channel, Application, End User)
  • US
  • Canada
• Europe (Product Type, Raw Material, Distribution Channel, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Raw Material, Distribution Channel, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Raw Material, Distribution Channel, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Raw Material, Distribution Channel, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Capsule Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Now Health Group Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProCaps Group (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Super Spectrim (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Sirio Pharma Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soft Gel Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EuroCaps Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geltec Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Captek Softgel International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elnova Pharma (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Formulations (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmavite LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Robinson Pharma, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations